Lack of BRAF V600E mutation in human myeloma cell lines established from myeloma patients with extramedullary disease

類似資料

• The Bcl-2 specific BH3 mimetic ABT-199: a promising targeted therapy for t(11;14) multiple myeloma
  著者:: Touzeau, C, 等
  出版事項: (2014)
• Paradoxical effect of lenalidomide on cytokine/growth factor profiles in multiple myeloma
  著者:: Maïga, S, 等
  出版事項: (2013)
• A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines
  著者:: Moreaux, Jérôme, 等
  出版事項: (2011)
• Whole-exon sequencing of human myeloma cell lines shows mutations related to myeloma patients at relapse with major hits in the DNA regulation and repair pathways
  著者:: Tessoulin, Benoît, 等
  出版事項: (2018)
• Combination of lenalidomide with vitamin D3 induces apoptosis in mantle cell lymphoma via demethylation of BIK
  著者:: Brosseau, C, 等
  出版事項: (2014)